Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study
A Hoxha, N Perin, M Lovisotto, A Calligaro… - Journal of …, 2024 - Elsevier
Background Despite anticoagulant therapy, a antiphospholipid syndrome (APS) has a
higher rate of recurrent events, which can lead to damage accrual and a negative impact on …
higher rate of recurrent events, which can lead to damage accrual and a negative impact on …
[PDF][PDF] Antifosfolipidantistoffer og antifosfolipidsyndrom
RS Hansen, JB Larsen, P Vinholt, A Voss… - Ugeskrift for …, 2024 - content.ugeskriftet.dk
Personer med antifosfolipidantistoffer (aPL), dvs. autoantistoffer der interagerer med
fosfolipidbindende plasmaproteiner, har øget risiko for bl. a. arteriel trombose (ATE), venøs …
fosfolipidbindende plasmaproteiner, har øget risiko for bl. a. arteriel trombose (ATE), venøs …